Spheroid Culture of Mesenchymal Stem Cells

Stem Cells International

Volumn 2016, Issue , 2016, Pages

  Cesarz, Zoe ^a   Tamama, Kenichi ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EARLY GROWTH RESPONSE FACTOR 2; FIBROBLAST GROWTH FACTOR 2; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 2ALPHA; INTERLEUKIN 1; OCTAMER TRANSCRIPTION FACTOR 4; SCATTER FACTOR; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2; VASCULOTROPIN A;

ACTB GENE; ANG GENE; ANGPT2 GENE; ANTIANGIOGENIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CELL ADHESION; CELL DIFFERENTIATION; CELL STRUCTURE; CELL SURVIVAL; CYTOLOGY; CYTOSKELETON; EPIGENETICS; FGF2 GENE; GENE; GENE EXPRESSION; HGF GENE; HUMAN; IN VITRO STUDY; MECHANICS; MESENCHYMAL STEM CELL; MICROARRAY ANALYSIS; MOLECULAR BIOLOGY; NANOG GENE; NEURAL STEM CELL; NONHUMAN; OCT4 GENE; ONCOLOGY; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SENESCENCE; SIGNAL TRANSDUCTION; SOX2 GENE; SPHEROID CULTURE; STEM CELL CULTURE; STEM CELL EXPANSION; THREE DIMENSIONAL IMAGING; TISSUE REGENERATION; TISSUE REPAIR; UPREGULATION; VEGFA GENE;

EID: 84948798671     PISSN: None     EISSN: 16879678     Source Type: Journal    
DOI: 10.1155/2016/9176357     Document Type: Review

References (138)

1. A. J. Friedenstein, U. F. Gorskaja, and N. N. Kulagina, "Fibroblast precursors in normal and irradiated mouse hematopoietic organs," Experimental Hematology, vol. 4, no. 5, pp. 267-274, 1976.
2. M. Owen and A. J. Friedenstein, "Stromal stem cells: marrowderived osteogenic precursors," Ciba Foundation Symposium, vol. 136, pp. 42-60, 1988.
3. M. F. Pittenger, A. M. Mackay, S. C. Beck et al., "Multilineage potential of adult human mesenchymal stem cells," Science, vol. 284, no. 5411, pp. 143-147, 1999.
4. D. J. Prockop, "Marrow stromal cells as stem cells for nonhematopoietic tissues," Science, vol. 276, no. 5309, pp. 71-74, 1997.
5. K. Tamama, V. H. Fan, L. G. Griffith, H. C. Blair, and A. Wells, "Epidermal growth factor as a candidate for ex vivo expansion of bone marrow-derived mesenchymal stem cells," Stem Cells, vol. 24, no. 3, pp. 686-695, 2006.
6. K. Tamama, C. K. Sen, and A. Wells, "Differentiation of bone marrow mesenchymal stem cells into the smooth muscle lineage by blocking ERK/MAPK signaling pathway," Stem Cells and Development, vol. 17, no. 5, pp. 897-908, 2008.
7. K. Tamama and D. J. Barbeau, "Early growth response genes signaling supports strong paracrine capability of mesenchymal stem cells," Stem Cells International, vol. 2012, Article ID 428403, 7 pages, 2012.
8. K. Tamama, H. Kawasaki, and A. Wells, "Epidermal growth factor (EGF) treatment onmultipotential stromal cells (MSCs). Possible enhancement of therapeutic potential of MSC," Journal of Biomedicine and Biotechnology, vol. 2010, Article ID 795385, 10 pages, 2010.
9. W. Mueller-Klieser, "Multicellular spheroids-a review on cellular aggregates in cancer research," Journal of Cancer Research and Clinical Oncology, vol. 113, no. 2, pp. 101-122, 1987.
10. W. Mueller-Klieser, "Three-dimensional cell cultures: from molecular mechanisms to clinical applications," American Journal of Physiology-Cell Physiology, vol. 273, no. 4, pp. C1109-C1123, 1997.
11. Y. Sasai, "Next-generation regenerative medicine: organogenesis from stem cells in 3D culture," Cell Stem Cell, vol. 12, no. 5, pp. 520-530, 2013.
12. Y. Sasai, "Cytosystems dynamics in self-organization of tissue architecture," Nature, vol. 493, no. 7432, pp. 318-326, 2013.
13. S. Sart, A. C. Tsai, Y. Li, and T. Ma, "Three-dimensional aggregates of mesenchymal stem cells: cellular mechanisms, biological properties, and applications," Tissue Engineering Part B: Reviews, vol. 20, no. 5, pp. 365-380, 2014.
14. L. Vallier and R. A. Pedersen, "Human embryonic stem cells: an in vitromodel to studymechanisms controlling pluripotency in earlymammalian development," Stem Cell Reviews, vol. 1, no. 2, pp. 119-130, 2005.
15. R. Z. Lin and H. Y. Chang, "Recent advances in three-dimensional multicellular spheroid culture for biomedical research," Biotechnology Journal, vol. 3, no. 9-10, pp. 1172-1184, 2008.
16. T.-M. Achilli, J. Meyer, and J. R. Morgan, "Advances in the formation, use and understanding of multi-cellular spheroids," Expert Opinion on Biological Therapy, vol. 12, no. 10, pp. 1347-1360, 2012.
17. F. Grinnell and M. K. Feld, "Adsorption characteristics of plasma fibronectin in relationship to biological activity," Journal of Biomedical Materials Research, vol. 15, no. 3, pp. 363-381, 1981.
18. E. Ruoslahti and M. D. Pierschbacher, "New perspectives in cell adhesion: RGD and integrins," Science, vol. 238, no. 4826, pp. 491-497, 1987.
19. J. A. Zimmermann and T. C. Mcdevitt, "Pre-conditioning mesenchymal stromal cell spheroids for immunomodulatory paracrine factor secretion," Cytotherapy, vol. 16, no. 3, pp. 331-345, 2014.
20. R. Foty, "A simple hanging drop cell culture protocol for generation of 3D spheroids," Journal of Visualized Experiments, no. 51, Article ID e2720, 2011.
21. G.-S. Huang, L.-G. Dai, B. L. Yen, and S.-H. Hsu, "Spheroid formation ofmesenchymal stem cells on chitosan and chitosanhyaluronan membranes," Biomaterials, vol. 32, no. 29, pp. 6929-6945, 2011.
22. S. Schmidt and P. Friedl, "Interstitial cell migration: integrindependent and alternative adhesion mechanisms," Cell and Tissue Research, vol. 339, no. 1, pp. 83-92, 2010.
23. T. J. Bartosh, J. H. Ylöstalo, N. Bazhanov, J. Kuhlman, and D. J. Prockop, "Dynamic compaction of human mesenchymal stem/precursor cells into spheres self-activates caspasedependent il1 signaling to enhance secretion of modulators of inflammation and immunity (PGE2, TSG6, and STC1)," Stem Cells, vol. 31, no. 11, pp. 2443-2456, 2013.
24. A.C. Tsai, Y. Liu, X. Yuan, and T. Ma, "Compaction, fusion, and functional activation of three-dimensional human mesenchymal stem cell aggregate," Tissue Engineering A, 2015.
25. H. Y. Yeh, B. H. Liu, and S. H. Hsu, "The calcium-dependent regulation of spheroid formation and cardiomyogenic differentiation for MSCs on chitosanmembranes," Biomaterials, vol. 33, no. 35, pp. 8943-8954, 2012.
26. E. J. Lee, S. J. Park, S. K. Kang et al., "Spherical bullet formation via E-cadherin promotes therapeutic potency of mesenchymal stem cells derived from human umbilical cord blood for myocardial infarction," Molecular Therapy, vol. 20, no. 7, pp. 1424-1433, 2012.
27. J. Kim and T. Ma, "Endogenous extracellular matrices enhance human mesenchymal stem cell aggregate formation and survival," Biotechnology Progress, vol. 29, no. 2, pp. 441-451, 2013.
28. H.-Y. Yeh, B.-H. Liu, M. Sieber, and S.-H. Hsu, "Substratedependent gene regulation of self-assembled human MSC spheroids on chitosan membranes," BMC Genomics, vol. 15, no. 1, article 10, 2014.
29. H. Dertinger and C. L. Huhle, "A comparative study of postirradiation growth kinetics of spheroids and monolayers," International Journal of Radiation Biology, vol. 28, no. 3, pp. 255-265, 1975.
30. R. E. Durand, "Cell cycle kinetics in an in vitro tumor model," Cell and Tissue Kinetics, vol. 9, no. 5, pp. 403-412, 1976.
31. M. Haji-Karim and J. Carlsson, "Proliferation and viability in cellular spheroids of human origin," Cancer Research, vol. 38, no. 5, pp. 1457-1464, 1978.
32. J. M. Yuhas and A. P. Li, "Growth fraction as the major determinant of multicellular tumor spheroid growth rates," Cancer Research, vol. 38, no. 6, pp. 1528-1532, 1978.
33. J. Carlsson, C.-G. Stålnacke, H. Acker, M. Haji-Karim, S. Nilsson, and B. Larsson, "The influence of oxygen on viability and proliferation in cellular spheroids," International Journal of Radiation Oncology, Biology, Physics, vol. 5, no. 11-12, pp. 2011-2020, 1979.
34. J. C. Angello and H. L. Hosick, "Glycosaminoglycan synthesis by mammary tumor spheroids," Biochemical and Biophysical Research Communications, vol. 107, no. 3, pp. 1130-1137, 1982.
35. T. Nederman, B. Norling, B. Glimelius, J. Carlsson, and U. Brunk, "Demonstration of an extracellular matrix in multicellular tumor spheroids," Cancer Research, vol. 44, no. 7, pp. 3090-3097, 1984.
36. R. M. Sutherland, W. R. Inch, J. A. McCredie, and J. Kruuv, "A multi-component radiation survival curve using an in vitro tumour model," International Journal of Radiation Biology and Related Studies in Physics, Chemistry, and Medicine, vol. 18, no. 5, pp. 491-495, 1970.
37. R. E. Durand and R. M. Sutherland, "Effects of intercellular contact on repair of radiation damage," Experimental Cell Research, vol. 71, no. 1, pp. 75-80, 1972.
38. R. E. Durand and R. M. Sutherland, "Dependence of the radiation response of an in vitro tumor model on cell cycle effects," Cancer Research, vol. 33, no. 2, pp. 213-219, 1973.
39. R. E. Durand and R. M. Sutherland, "Growth and radiation survival characteristics of V79-171b Chinese hamster cells: a possible influence of intercellular contact," Radiation Research, vol. 56, no. 3, pp. 513-527, 1973.
40. G. Kats-Ugurlu, I. Roodink, M. de Weijert et al., "Circulating tumour tissue fragments in patients with pulmonarymetastasis of clear cell renal cell carcinoma," Journal of Pathology, vol. 219, no. 3, pp. 287-293, 2009.
41. E. H. Cho, M. Wendel, M. Luttgen et al., "Characterization of circulating tumor cell aggregates identified in patients with epithelial tumors," Physical Biology, vol. 9, no. 1, Article ID 016001, 2012.
42. V. V. Glinsky, G. V. Glinsky, O. V. Glinskii et al., "Intravascular metastatic cancer cell homotypic aggregation at the sites of primary attachment to the endothelium," Cancer Research, vol. 63, no. 13, pp. 3805-3811, 2003.
43. M. J. Evans and M. H. Kaufman, "Establishment in culture of pluripotential cells from mouse embryos," Nature, vol. 292, no. 5819, pp. 154-156, 1981.
44. G. R. Martin, "Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells," Proceedings of the National Academy of Sciences of the United States of America, vol. 78, no. 12, pp. 7634-7638, 1981.
45. A. Grover, R. G. Oshima, and E. D. Adamson, "Epithelial layer formation in differentiating aggregates of F9 embryonal carcinoma cells," Journal of Cell Biology, vol. 96, no. 6, pp. 1690-1696, 1983.
46. S. Ahmed, "The culture of neural stem cells," Journal of Cellular Biochemistry, vol. 106, no. 1, pp. 1-6, 2009.
47. J. B. Jensen and M. Parmar, "Strengths and limitations of the neurosphere culture system," Molecular Neurobiology, vol. 34, no. 3, pp. 153-161, 2006.
48. K. Okumura, K. Nakamura, Y. Hisatomi et al., "Salivary gland progenitor cells induced by duct ligation differentiate into hepatic and pancreatic lineages," Hepatology, vol. 38, no. 1, pp. 104-113, 2003.
49. K. Watanabe, D. Kamiya, A. Nishiyama et al., "Directed differentiation of telencephalic precursors from embryonic stem cells," Nature Neuroscience, vol. 8, no. 3, pp. 288-296, 2005.
50. T. J. Bartosh, J. H. Ylöstalo, A. Mohammadipoor et al., "Aggregation of human mesenchymal stromal cells (MSCs) into 3D spheroids enhances their antiinflammatory properties," Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 31, pp. 13724-13729, 2010.
51. Q. Zhang, A. L. Nguyen, S. Shi et al., "Three-dimensional spheroid culture of human gingiva-derived mesenchymal stem cells enhances mitigation of chemotherapy-induced oral mucositis," Stem Cells and Development, vol. 21, no. 6, pp. 937-947, 2012.
52. P. R. Baraniak, M. T. Cooke, R. Saeed, M. A. Kinney, K. M. Fridley, and T. C. McDevitt, "Stiffening of human mesenchymal stem cell spheroid microenvironments induced by incorporation of gelatin microparticles," Journal of the Mechanical Behavior of Biomedical Materials, vol. 11, pp. 63-71, 2012.
53. E. Bellas and C. S. Chen, "Forms, forces, and stem cell fate," Current Opinion in Cell Biology, vol. 31, pp. 92-97, 2014.
54. R. McBeath, D.M. Pirone, C. M. Nelson, K. Bhadriraju, and C. S. Chen, "Cell shape, cytoskeletal tension, and RhoA regulate stem cell lineage commitment," Developmental Cell, vol. 6, no. 4, pp. 483-495, 2004.
55. S. A. Ruiz and C. S. Chen, "Emergence of patterned stem cell differentiation within multicellular structures," Stem Cells, vol. 26, no. 11, pp. 2921-2927, 2008.
56. J. H. Wen, L. G. Vincent, A. Fuhrmann et al., "Interplay of matrix stiffness and protein tethering in stem cell differentiation," Nature Materials, vol. 13, no. 10, pp. 979-987, 2014.
57. W. L. Murphy, T. C. McDevitt, and A. J. Engler, "Materials as stem cell regulators," Nature Materials, vol. 13, no. 6, pp. 547-557, 2014.
58. I. A. Potapova, G. R. Gaudette, P. R. Brink et al., "Mesenchymal stem cells support migration, extracellular matrix invasion, proliferation, and survival of endothelial cells in vitro," Stem Cells, vol. 25, no. 7, pp. 1761-1768, 2007.
59. I. A. Potapova, P. R. Brink, I. S. Cohen, and S. V. Doronin, "Culturing of human mesenchymal stem cells as three-dimensional aggregates induces functional expression of CXCR4 that regulates adhesion to endothelial cells," The Journal of Biological Chemistry, vol. 283, no. 19, pp. 13100-13107, 2008.
60. J. E. Frith, B. Thomson, and P. G. Genever, "Dynamic threedimensional culture methods enhance mesenchymal stem cell properties and increase therapeutic potential," Tissue Engineering Part C: Methods, vol. 16, no. 4, pp. 735-749, 2010.
61. R. H. Lee, M. J. Seo, A. A. Pulin, C. A. Gregory, J. Ylostalo, and D. J. Prockop, "The CD34-like protein PODXL and α6-integrin (CD49f) identify early progenitor MSCs with increased clonogenicity and migration to infarcted heart in mice," Blood, vol. 113, no. 4, pp. 816-826, 2009.
62. R. H. Lee, A. A. Pulin, M. J. Seo et al., "Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6," Cell Stem Cell, vol. 5, no. 1, pp. 54-63, 2009.
63. M. Crisan, S. Yap, L. Casteilla et al., "A perivascular origin for mesenchymal stem cells in multiple human organs," Cell Stem Cell, vol. 3, no. 3, pp. 301-313, 2008.
64. + perivascular cells and fibroblasts," Experimental Hematology, vol. 36, no. 5, pp. 642-654, 2008.
65. D.T. Covas, C.E. Piccinato, M. D. Orellana et al., "Mesenchymal stem cells can be obtained from the human saphena vein," Experimental Cell Research, vol. 309, no. 2, pp. 340-344, 2005.
66. M. Abedin, Y. Tintut, and L. L. Demer, "Mesenchymal stem cells and the artery wall," Circulation Research, vol. 95, no. 7, pp. 671-676, 2004.
67. A. I. Caplan, "AllMSCs are pericytes?" Cell Stem Cell, vol. 3, no. 3, pp. 229-230, 2008.
68. C. Lamagna and G. Bergers, "The bone marrow constitutes a reservoir of pericyte progenitors," Journal of Leukocyte Biology, vol. 80, no. 4, pp. 677-681, 2006.
69. A. I. Caplan, "Why are MSCs therapeutic? New data: new insight," Journal of Pathology, vol. 217, no. 2, pp. 318-324, 2009.
70. L. Diaz-Flores Jr., R. Gutierrez, J. F. Madrid, H. Varela, F. Valladares, and L. Diaz-Flores, "Adult stem cells and repair through granulation tissue," Frontiers in Bioscience, vol. 14, no. 4, pp. 1433-1470, 2009.
71. K. English, A. French, and K. J. Wood, "Mesenchymal stromal cells: facilitators of successful transplantation?" Cell Stem Cell, vol. 7, no. 4, pp. 431-442, 2010.
72. J. Galipeau, "The mesenchymal stromal cells dilemma-does a negative phase III trial of random donor mesenchymal stromal cells in steroid-resistant graft-versus-host disease represent a death knell or a bump in the road?" Cytotherapy, vol. 15, no. 1, pp. 2-8, 2013.
73. J. Tongers, D. W. Losordo, and U. Landmesser, "Stem and progenitor cell-based therapy in ischaemic heart disease: promise, uncertainties, and challenges," European Heart Journal, vol. 32, no. 10, pp. 1197-1206, 2011.
74. M. Krampera, "Mesenchymal stromal cell 'licensing': a multistep process," Leukemia, vol. 25, no. 9, pp. 1408-1414, 2011.
75. A. Uccelli, L. Moretta, and V. Pistoia, "Mesenchymal stem cells in health and disease," Nature Reviews Immunology, vol. 8, no. 9, pp. 726-736, 2008.
76. J. A. Ankrum, J. F. Ong, and J. M. Karp, "Mesenchymal stem cells: immune evasive, not immune privileged," Nature Biotechnology, vol. 32, no. 3, pp. 252-260, 2014.
77. D. J. Prockop, "Concise review: two negative feedback loops place mesenchymal stem/stromal cells at the center of early regulators of inflammation," Stem Cells, vol. 31, no. 10, pp. 2042-2046, 2013.
78. J. H. Ylöstalo, T. J. Bartosh, K. Coble, and D. J. Prockop, "Human mesenchymal stem/stromal cells cultured as spheroids are selfactivated to produce prostaglandin E2 that directs stimulated macrophages into an anti-inflammatory phenotype," Stem Cells, vol. 30, no. 10, pp. 2283-2296, 2012.
79. C. Menard, L. Pacelli, G. Bassi et al., "Clinical-grade mesenchymal stromal cells produced under various good manufacturing practice processes differ in their immunomodulatory properties: standardization of immune quality controls," Stem Cells and Development, vol. 22, no. 12, pp. 1789-1801, 2013.
80. Y. Shi, J. Su, A. I. Roberts, P. Shou, A. B. Rabson, and G. Ren, "How mesenchymal stem cells interact with tissue immune responses," Trends in Immunology, vol. 33, no. 3, pp. 136-143, 2012.
81. Y. Zhou, A. Day, S. Haykal, A. Keating, and T. K. Waddell, "Mesenchymal stromal cells augment CD4+ and CD8+ T-cell proliferation through a CCL2 pathway," Cytotherapy, vol. 15, no. 10, pp. 1195-1207, 2013.
82. M. J. Hoogduijn, M. Roemeling-van Rhijn, A. U. Engela et al., "Mesenchymal stem cells induce an inflammatory response after intravenous infusion," Stem Cells and Development, vol. 22, no. 21, pp. 2825-2835, 2013.
83. K. Anton, D. Banerjee, and J. Glod, "Macrophage-associated mesenchymal stem cells assume an activated, migratory, proinflammatory phenotype with increased IL-6 and CXCL10 secretion," PLoS ONE, vol. 7, no. 4, Article ID e35036, 2012.
84. G. Ren, L. Zhang, X. Zhao et al., "Mesenchymal stem cellmediated immunosuppression occurs via concerted action of chemokines and nitric oxide," Cell Stem Cell, vol. 2, no. 2, pp. 141-150, 2008.
85. G. C. Gurtner, S. Werner, Y. Barrandon, and M. T. Longaker, "Wound repair and regeneration," Nature, vol. 453, no. 7193, pp. 314-321, 2008.
86. M. W. J. Ferguson and S. O'Kane, "Scar-free healing: from embryonic mechanism to adult therapeutic intervention," Philosophical Transactions of the Royal Society of London B: Biological Sciences, vol. 359, no. 1445, pp. 839-850, 2004.
87. D. Hanahan, "Signaling vascular morphogenesis and maintenance," Science, vol. 277, no. 5322, pp. 48-50, 1997.
88. H. G. Augustin, G. Y. Koh, G. Thurston, and K. Alitalo, "Control of vascular morphogenesis and homeostasis through the angiopoietin-tie system," Nature Reviews Molecular Cell Biology, vol. 10, no. 3, pp. 165-177, 2009.
89. Y. Cao, J. Arbiser, R. J. D'Amato et al., "Forty-year journey of angiogenesis translational research," Science Translational Medicine, vol. 3, no. 114, Article ID 114rv3, 2011.
90. M. Nomi, H. Miyake, Y. Sugita, M. Fujisawa, and S. Soker, "Role of growth factors and endothelial cells in therapeutic angiogenesis and tissue engineering," Current Stem Cell Research & Therapy, vol. 1, no. 3, pp. 333-343, 2006.
91. E. Gherardi, W. Birchmeier, C. Birchmeier, and G. V. Woude, "Targeting MET in cancer: rationale and progress," Nature Reviews Cancer, vol. 12, no. 2, pp. 89-103, 2012.
92. M. W. Laschke, T. E. Schank, C. Scheuer et al., "Threedimensional spheroids of adipose-derived mesenchymal stem cells are potent initiators of blood vessel formation in porous polyurethane scaffolds," Acta Biomaterialia, vol. 9, no. 6, pp. 6876-6884, 2013.
93. S. H. Bhang, S. Lee, J.-Y. Shin, T.-J. Lee, and B.-S. Kim, "Transplantation of cord blood mesenchymal stem cells as spheroids enhances vascularization," Tissue Engineering Part A, vol. 18, no. 19-20, pp. 2138-2147, 2012.
94. M. Fu, J. Zhang, Y. Lin, X. Zhu, M. U. Ehrengruber, and Y. E. Chen, "Early growth response factor-1 is a critical transcriptional mediator of peroxisome proliferator-activated receptor-γ1 gene expression in human aortic smooth muscle cells," The Journal of Biological Chemistry, vol. 277, no. 30, pp. 26808-26814, 2002.
95. N.-C. Cheng, S.-Y. Chen, J.-R. Li, and T.-H. Young, "Shortterm spheroid formation enhances the regenerative capacity of adipose-derived stem cells by promoting stemness, angiogenesis, and chemotaxis," Stem Cells Translational Medicine, vol. 2, no. 8, pp. 584-594, 2013.
96. C. L. Rettinger, A. B. Fourcaudot, S. J. Hong, T. A. Mustoe, R. G. Hale, and K. P. Leung, "In vitro characterization of scaffold-free three-dimensional mesenchymal stem cell aggregates," Cell and Tissue Research, vol. 358, no. 2, pp. 395-405, 2014.
97. W. M. Jackson, L. J. Nesti, and R. S. Tuan, "Mesenchymal stem cell therapy for attenuation of scar formation during wound healing," Stem Cell Research & Therapy, vol. 3, no. 3, article 20, 2012.
98. B. Johnstone, T. M. Hering, A. I. Caplan, V. M. Goldberg, and J. U. Yoo, "In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells," Experimental Cell Research, vol. 238, no. 1, pp. 265-272, 1998.
99. J. U. Yoo, T. S. Barthel, K. Nishimura et al., "The chondrogenic potential of human bone-marrow-derived mesenchymal progenitor cells," The Journal of Bone & Joint Surgery-American Volume, vol. 80, no. 12, pp. 1745-1757, 1998.
100. A. M. Mackay, S. C. Beck, J. M. Murphy, F. P. Barry, C. O. Chichester, and M. F. Pittenger, "Chondrogenic differentiation of cultured human mesenchymal stem cells from marrow," Tissue Engineering, vol. 4, no. 4, pp. 415-428, 1998.
101. W. Wang, K. Itaka, S. Ohba et al., "3D spheroid culture system on micropatterned substrates for improved differentiation efficiency of multipotent mesenchymal stem cells," Biomaterials, vol. 30, no. 14, pp. 2705-2715, 2009.
102. N.-C. Cheng, S. Wang, and T.-H. Young, "The influence of spheroid formation of human adipose-derived stem cells on chitosan films on stemness and differentiation capabilities," Biomaterials, vol. 33, no. 6, pp. 1748-1758, 2012.
103. + human mesenchymal stem cells into chondrocyte-like cells through spheroid formation," Journal of Cellular Biochemistry, vol. 108, no. 1, pp. 145-155, 2009.
104. Y. Miyagawa, H. Okita, M. Hiroyama et al., "A microfabricated scaffold induces the spheroid formation of human bone marrow-derived mesenchymal progenitor cells and promotes efficient adipogenic differentiation," Tissue Engineering A, vol. 17, no. 3-4, pp. 513-521, 2011.
105. C. J. Lengner, F. D. Camargo, K. Hochedlinger et al., "Oct4 expression is not required for mouse somatic stem cell selfrenewal," Cell Stem Cell, vol. 1, no. 4, pp. 403-415, 2007.
106. J. S. Berg and M. A. Goodell, "An argument against a role for Oct4 in somatic stemcells," Cell Stem Cell, vol. 1, no. 4, pp. 359-360, 2007.
107. R. Pochampally, "Colony forming unit assays for MSCs," Methods in Molecular Biology, vol. 449, pp. 83-91, 2008.
108. L. Guo, Y. Zhou, S. Wang, and Y. Wu, "Epigenetic changes of mesenchymal stem cells in three-dimensional (3D) spheroids," Journal of Cellular and Molecular Medicine, vol. 18, no. 10, pp. 2009-2019, 2014.
109. I. Sekiya, B.L. Larson, J. R. Smith, R. Pochampally, J.-G. Cui, and D. J. Prockop, "Expansion of human adult stem cells from bone marrow stroma: conditions that maximize the yields of early progenitors and evaluate their quality," Stem Cells, vol. 20, no. 6, pp. 530-541, 2002.
110. J. Campisi, "Replicative senescence: an old lives' tale?" Cell, vol. 84, no. 4, pp. 497-500, 1996.
111. J. Campisi, "From cells to organisms: can we learn about aging fromcells in culture?" Experimental Gerontology, vol. 36, no. 4-6, pp. 607-618, 2001.
112. G. Lepperdinger, R. Brunauer, A. Jamnig, G. Laschober, and M. Kassem, "Controversial issue: is it safe to employ mesenchymal stem cells in cell-based therapies?" Experimental Gerontology, vol. 43, no. 11, pp. 1018-1023, 2008.
113. P. R. Crisostomo, M. Wang, G.M. Wairiuko et al., "High passage number of stem cells adversely affects stem cell activation and myocardial protection," Shock, vol. 26, no. 6, pp. 575-580, 2006.
114. S. Jiang, H. K. Haider, R. P. H. Ahmed, N. M. Idris, A. Salim, and M. Ashraf, "Transcriptional profiling of young and old mesenchymal stem cells in response to oxygen deprivation and reparability of the infarcted myocardium," Journal of Molecular and Cellular Cardiology, vol. 44, no. 3, pp. 582-596, 2008.
115. C. Fehrer and G. Lepperdinger, "Mesenchymal stem cell aging," Experimental Gerontology, vol. 40, no. 12, pp. 926-930, 2005.
116. M. E. Menezes, S. Bhatia, P. Bhoopathi et al., "MDA-7/IL-24: multifunctional cancer killing cytokine," in Anticancer Genes, vol. 818 of Advances in Experimental Medicine and Biology, pp. 127-153, Springer, London, UK, 2014.
117. P. Dent, A. Yacoub, H. A. Hamed et al., "MDA-7/IL-24 as a cancer therapeutic: frombench to bedside," Anti-Cancer Drugs, vol. 21, no. 8, pp. 725-731, 2010.
118. M. Sauane, R. V. Gopalkrishnan, D. Sarkar et al., "MDA-7/IL-24: novel cancer growth suppressing and apoptosis inducing cytokine," Cytokine and Growth Factor Reviews, vol. 14, no. 1, pp. 35-51, 2003.
119. I. A. Droujinine, M. A. Eckert, and W. Zhao, "To grab the stroma by the horns: frombiology to cancer therapy withmesenchymal stem cells," Oncotarget, vol. 4, no. 5, pp. 651-664, 2013.
120. N. Serakinci, U. Fahrioglu, and R. Christensen, "Mesenchymal stem cells, cancer challenges and new directions," European Journal of Cancer, vol. 50, no. 8, pp. 1522-1530, 2014.
121. M. Rodrigues, L. G. Griffith, and A. Wells, "Growth factor regulation of proliferation and survival of multipotential stromal cells," Stem Cell Research and Therapy, vol. 1, no. 4, article 32, 2010.
122. C. Toma, M. F. Pittenger, K. S. Cahill, B. J. Byrne, and P. D. Kessler, "Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart," Circulation, vol. 105, no. 1, pp. 93-98, 2002.
123. C. Toma, W. R. Wagner, S. Bowry, A. Schwartz, and F. Villanueva, "Fate of culture-expanded mesenchymal stem cells in the microvasculature: in vivo observations of cell kinetics," Circulation Research, vol. 104, no. 3, pp. 398-402, 2009.
124. L. von Bahr, I. Batsis, G. Moll et al., "Analysis of tissues following mesenchymal stromal cell therapy in humans indicates limited long-term engraftment and no ectopic tissue formation," Stem Cells, vol. 30, no. 7, pp. 1575-1578, 2012.
125. G. L. Semenza, "Oxygen-dependent regulation of mitochondrial respiration by hypoxia-inducible factor 1," Biochemical Journal, vol. 405, no. 1, pp. 1-9, 2007.
126. W. L. Grayson, F. Zhao, B. Bunnell, and T. Ma, "Hypoxia enhances proliferation and tissue formation of human mesenchymal stem cells," Biochemical and Biophysical Research Communications, vol. 358, no. 3, pp. 948-953, 2007.
127. K. Tamama, H. Kawasaki, S. S. Kerpedjieva, J. Guan, R. K. Ganju, and C. K. Sen, "Differential roles of hypoxia inducible factor subunits in multipotential stromal cells under hypoxic condition," Journal of Cellular Biochemistry, vol. 112, no. 3, pp. 804-817, 2011.
128. L. Song, N. E. Webb, Y. Song, and R. S. Tuan, "Identification and functional analysis of candidate genes regulating mesenchymal stem cell self-renewal andmultipotency," Stem Cells, vol. 24, no. 7, pp. 1707-1718, 2006.
129. D. J. Barbeau, K. T. La, D. S. Kim, S. S. Kerpedjieva, G. V. Shurin, and K. Tamama, "Early growth response-2 signaling mediates immunomodulatory effects of human multipotential stromal cells," Stem Cells and Development, vol. 23, no. 2, pp. 155-166, 2014.
130. K. A. Hogquist, M. A. Nett, E. R. Unanue, and D. D. Chaplin, "Interleukin 1 is processed and released during apoptosis," Proceedings of the National Academy of Sciences of the United States of America, vol. 88, no. 19, pp. 8485-8489, 1991.
131. R. J. Kaufman and J. D. Malhotra, "Calcium trafficking integrates endoplasmic reticulum function with mitochondrial bioenergetics," Biochimica et Biophysica Acta-Molecular Cell Research, vol. 1843, no. 10, pp. 2233-2239, 2014.
132. S. Orrenius, B. Zhivotovsky, and P. Nicotera, "Regulation of cell death: the calcium-apoptosis link," Nature Reviews Molecular Cell Biology, vol. 4, no. 7, pp. 552-565, 2003.
133. 2+ transfer in the control of apoptosis," Oncogene, vol. 27, no. 50, pp. 6407-6418, 2008.
134. R. Bonasio, S. Tu, and D. Reinberg, "Molecular signals of epigenetic states," Science, vol. 330, no. 6004, pp. 612-616, 2010.
135. H. Cedar and Y. Bergman, "Linking DNA methylation and histone modification: patterns and paradigms," Nature Reviews Genetics, vol. 10, no. 5, pp. 295-304, 2009.
136. G. Egger, G. Liang, A. Aparicio, and P. A. Jones, "Epigenetics in human disease and prospects for epigenetic therapy," Nature, vol. 429, no. 6990, pp. 457-463, 2004.
137. A. Watanabe, Y. Yamada, and S. Yamanaka, "Epigenetic regulation in pluripotent stem cells: a key to breaking the epigenetic barrier," Philosophical transactions of the Royal Society of London. Series B, Biological sciences, vol. 368, no. 1609, Article ID 20120292, 2013.
138. H. Nishida, T. Suzuki, S. Kondo, H. Miura, Y.-I. Fujimura, and Y. Hayashizaki, "Histone H3 acetylated at lysine 9 in promoter is associated with low nucleosome density in the vicinity of transcription start site in human cell," Chromosome Research, vol. 14, no. 2, pp. 203-211, 2006.